GMAB

GMAB

USD

Genmab A/S ADS

$28.975+0.435 (1.524%)

即時價格

Healthcare
生物科技
丹麥

價格圖表

Loading Chart...

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$28.540

最高

$29.390

最低

$28.510

交易量

2.92M

公司基本面

市值

17.8B

行業

生物科技

國家

Denmark

交易統計

平均交易量

2.00M

交易所

NMS

貨幣

USD

52週範圍

最低 $17.235當前 $28.975最高 $33.65

相關新聞

BusinessWire

Genmab to Showcase Latest Blood Cancer Treatment Advancements at 2025 American Society of Hematology (ASH) Annual Meeting

More than 20 abstracts, including seven oral presentations, highlight advancements from the epcoritamab development program supporting the expanded clinical profile and potential of epcoritamab for a broader range of

查看更多
Genmab to Showcase Latest Blood Cancer Treatment Advancements at 2025 American Society of Hematology (ASH) Annual Meeting
Analyst Upgrades

HC Wainwright & Co. Reiterates Buy on Genmab, Maintains $40 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Genmab with a Buy and maintains $40 price target.

查看更多
HC Wainwright & Co. Reiterates Buy on Genmab, Maintains $40 Price Target
GlobeNewswire

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2025

Company Announcement Net sales of DARZALEX® in the third quarter of 2025 totaled USD 3,672 millionGenmab receives royalties on worldwide net sales from Johnson & Johnson (J&J, legal entity Janssen Biotech,

查看更多
Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2025